Saudi-based private equity firm Jadwa Investment is preparing to divest its 51% stake in UniPharma, one of the kingdom’s largest pharmaceutical groups, in a deal that could value the company at SAR1bn ($267m) according to a report by Bloomberg.
The report cites unnamed sources familiar with the matter as revealing that Jadwa, which acquired the stake in 2020, has mandated EFG Holding’s investment banking arm to run the sale process, targeting both local and international private equity firms as well as strategic buyers.
The potential exit underscores Jadwa’s ongoing strategy of capital recycling in Saudi Arabia’s fast-expanding healthcare sector, following recent divestments in dental, dermatology, and general healthcare platforms.
UniPharma, the country’s largest pharmaceutical wholesaler, operates over 70 retail outlets nationwide.
